ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "macrophages"

  • Abstract Number: 3175 • 2016 ACR/ARHP Annual Meeting

    Longitudinal Analysis of MMF Clinical, Molecular, and Immunohistochemistry (IHC) Responses Shows SSc Patients Lose Their Inflammatory Signature and Rebound upon Treatment Cessation

    Diana Toledo1, Monique Hinchcliff2, Jaclyn Taroni1, Tammara A. Wood3, Jennifer Franks3, Sanjiv Shah4, Rishi Agrawal4, Lauren Beussink-Nelson4, Mary A. Carns5, Sofia Podlusky6, Patricia Pioli7 and Michael Whitfield3, 1Department of Molecular & Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 2Northwestern University, Feinberg School of Medicine Scleroderma Program, Chicago, IL, 3Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 4Northwestern University, Chicago, IL, 5Department of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, IL, 6Rheumatology Feinberg School of Medicine, Northwestern University, Chicago, IL, 7Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH

    Background/Purpose: We previously showed patients in the inflammatory subset were most likely to demonstrate improvement in modified Rodnan Skin Score (mRSS) during mycophenolate mofetil (MMF)…
  • Abstract Number: 793 • 2015 ACR/ARHP Annual Meeting

    Mesenchymal Stem Cells Promote the Generation of CD206+ Macrophage and Increase Its Phagocytic Activity in Systemic Lupus Erythematosus

    Wei Deng, Weiwei Chen, Zhuoya Zhang, Saisai Huang, Wei Kong, Yue Sun, Xuebing Feng, Xiaojun Tang, Genhong Yao and Lingyun Sun, Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China

    Background/Purpose: Umbilical cord (UC)-derived mesenchymal stem cells (MSCs) have been confirmed to exert therapeutic effects on systemic lupus erythematosus (SLE). Deficiency in SLE macrophages exhibits…
  • Abstract Number: 1033 • 2015 ACR/ARHP Annual Meeting

    Novel Ligand-Independent Peptide Inhibitors of Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) and T Cell Receptor (TCR): Efficacy in a Collagen-Induced Arthritis Model Suggests New Targeted Treatment for Rheumatoid Arthritis

    Zu T. Shen and Alexander B. Sigalov, SignaBlok, Inc., Shrewsbury, MA

    Background/Purpose: Macrophages and T cells are central to the pathophysiology of autoimmune diseases. Synovial macrophages, synovial fibroblasts and infiltrating T lymphocytes are the most abundant…
  • Abstract Number: 2151 • 2015 ACR/ARHP Annual Meeting

    Inhibition of Myeloid-Associated Gene Expression in Skin Biopsy Samples of Systemic Sclerosis Patients Treated with Tocilizumab

    Thierry Sornasse1, Haiyin Chen1, Lisa Rice2, Giuseppina Stifano2, Angelika Jahreis1, Jeffrey Siegel1 and Robert Lafyatis2, 1Genentech, South San Francisco, CA, 2Boston University School of Medicine, Boston, MA

    Background/Purpose: Systemic sclerosis (SSc) is a progressive, debilitating disease with limited treatment options. IL-6 has been implicated in disease pathogenesis. Tocilizumab (TCZ), an IL-6Rα inhibitor,…
  • Abstract Number: 2875 • 2014 ACR/ARHP Annual Meeting

    Macrophage Expression of Hypoxia-Inducible Factor-2 Alpha Promotes Rheumatoid Arthritis Progression

    Munitta Muthana1,2, William Jacob Hardy3, Sarah Hawtree1, Fiona Wright1, Ursula Fearon4, DJ Veale5, Mauro Perretti6 and Anthony G. Wilson7, 1Infection and Immunity, University of Sheffield, Sheffield, United Kingdom, 2Medical School, University of Sheffield, Sheffield, United Kingdom, 3University of Sheffield, Sheffield, United Kingdom, 4Dublin Academic Medical Centre, Translational Rheumatology Research Group, Dublin, Ireland, 5Consultant Rheumatologist, St. Vincent’s University Hospital, Dublin, Ireland, 6Biochemical Pharmaology, Barts and the London School of Medicine, London, United Kingdom, 7University College Dublin, Dublin, Ireland

    Background/Purpose Hypoxia exists in many diseased tissues including arthritic joints, atherosclerotic plaques and malignant tumours. Macrophages accumulate in these hypoxic sites where they possess broad…
  • Abstract Number: 2175 • 2014 ACR/ARHP Annual Meeting

    Macrophages from the Synovium of Active Rheumatoid Arthritis Exhibit an Activin a- Dependent Pro-Inflammatory Profile

    Elena Izquierdo1, Blanca Soler Palacios2, Lizbeth Estrada-Capetillo2, Gabriel Criado3, Concha Nieto1, Cristina Municio2, Isidoro González-Álvaro4, Paloma Sánchez-Mateos2, Jose L. Pablos5, Ángel L. Corbí1 and Amaya Puig-Kröger2, 1Microbiología Molecular y Biología de las Infecciones, Centro de Investigaciones Biologicas (CSIC), Madrid, Spain, 2Laboratorio de Inmuno-Metabolismo, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain, 3Servicio de reumatología, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain, 4Rheumatology Department, Hospital Universitario La Princesa, Instituto de Investigación Sanitaria Hospital Universitario La Princesa, Madrid, Spain, 5Servicio de Reumatología, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain

    Background/Purpose: Synovial macrophages are key effector cells in rheumatoid arthritis (RA), where they are a major source of pro-inflammatory cytokines and contribute to the cartilage…
  • Abstract Number: 1510 • 2014 ACR/ARHP Annual Meeting

    Blockade of TLR5 Ligation Is a Novel Strategy for RA Therapy  

    Seung-jae Kim1, Zhenlong Chen1, Abdul Essani2, Michael Volin3, Suncica Volkov1, William Swedler4, Shiva Arami2, Nadera J. Sweiss5 and Shiva Shahrara1, 1Medicine/Rheumatology, University of Illinois at Chicago, Chicago, IL, 2University of Illinois at Chicago, Chicago, IL, 3Microbiology & Immunology, Midwestern University, Downers Grove, IL, 4Section of Rheumatology, University of Illinois at Chicago, Chicago, IL, 5internal medicine section of rheumatology, University of Illinois at Chicago, Chicago, IL

    Background/Purpose: TLR5 expression is highly elevated in RA and CIA lining and sublining macrophages and endothelial cells compared to non-arthritic controls. Additionally, expression of TLR5…
  • Abstract Number: 1198 • 2014 ACR/ARHP Annual Meeting

    Prolactin Is Locally Produced in the Synovium of Patients with Inflammatory Arthritic Diseases and Promotes Macrophage Activation

    Man Wai Tang1, Samuel Garcia2, Danielle M. Gerlag3,4, Kris A. Reedquist5 and Paul P. Tak6,7, 1Division of Clinical Immunology and Rheumatology & Department of Experimental Immunology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands, 2Department of Experimental Immunology, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 3Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 4GlaxoSmithKline, Cambridge, United Kingdom, 5Department of Experimental Immunology and Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 6Division of Clinical Immunology and Rheumatology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands, 7University of Cambridge, Cambridge & GlaxoSmithKline, UK, Stevenage, United Kingdom

    Background/Purpose The sex hormone prolactin (PRL) has immunomodulatory properties, can be produced by immune cells, and elevated PRL serum levels have been reported in rheumatoid…
  • Abstract Number: 530 • 2013 ACR/ARHP Annual Meeting

    Pattern Recognition Receptor Stimulated Cytokine Expression By Spondyloarthritis Patient Macrophages

    Yi-Ping Liu1, Ashley Bomkamp2, Jens Eickhoff3, Jack Schneck2, Mike Khan4 and Judith Smith5, 1Department of Pediatrics, University of Wisconsin-Madison, Madison, WI, 2University of Wisconsin-Madison, Madison, WI, 3Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI, 4Cellular and Molecular Pathology, University of Wisconsin-Madison, Madison, WI, 5Pediatrics, University of Wisconsin-Madison, Madison, WI

    Background/Purpose: Spondyloarthritis (SpA) encompasses a group of chronic inflammatory conditions involving axial arthritis that includes ankylosing spondylitis (AS). GWAS studies in AS have implicated multiple…
  • Abstract Number: 1151 • 2013 ACR/ARHP Annual Meeting

    Snapin Is Required For Functional Autophagy and Is Critical For Monocyte To Macrophage Differentiation

    Bo Shi1, Qiquan Huang2, Robert Birkett1, Renee E. Koessler3, Andrea Dorfleutner4, Christian Stehlik4 and Richard M. Pope5, 1Division of Rheumatology, Department od Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Division of Rheumatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Medicine/Rheumatology, Northwestern University, Chicago, IL, 4Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 5Rheumatology, Northwestern University Feinberg school of Medicine, Chicago, IL

    Background/Purpose: Our recent data indicate that Snapin, a SNAP associated protein, is significantly increased in macrophages (MΦs) in rheumatoid arthritis (RA) synovial tissue and its…
  • Abstract Number: 1800 • 2012 ACR/ARHP Annual Meeting

    Macrophages in Hypoxic Rheumatoid Joints Preferentially Express Hypoxia Inducible Transcription Factor-2

    Sarah Aynsley1, Ursula Fearon2, Anthony G. Wilson1 and Munitta Muthana3, 1Infection and Immunity, University of Sheffield, Sheffield, United Kingdom, 2Rheumatology, Translation Research Group, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland, 3Infection and Immunity, University of sheffield, Sheffield, United Kingdom

    Background/Purpose: In rheumatoid arthritis (RA), the influx of inflammatory cells as well as the aggressive proliferation of fibroblast-like synovial cells (FLS) outstrips the oxygen supply…
  • Abstract Number: 1801 • 2012 ACR/ARHP Annual Meeting

    Biological Roles of C5orf30 in Rheumatoid Arthritis

    Munitta Muthana1, Sachin Khetan2, Gbadebo Adeleke Adeleke3, Simon Tazzyman3, Sarah Aynsley1, Fiona Morrow1, Sarah Hawtree1, Barbara Ciani4 and Anthony G. Wilson1, 1Infection and Immunity, University of Sheffield, Sheffield, United Kingdom, 2Infection and immunity, Dr, Sheffield, United Kingdom, 3Infection and Immunity, Dr, Sheffield, United Kingdom, 4Chemistry, University of Sheffield, Sheffield, United Kingdom

    Background/Purpose: A recent genome wide association study identified the variant rs26232 in the first exon of an uncharacterized gene C5orf30. In addition, this variant is…
  • Abstract Number: 1454 • 2012 ACR/ARHP Annual Meeting

    Characterization of Renal Mononuclear Phagocyte Populations in Murine SLE Nephritis

    Ranjit Sahu1, Ramalingam Bethunaickan2 and Anne Davidson1, 1Autoimmunity and Musculoskeletal Diseases, Feinstein Institute for Medical Research, Manhasset, NY, 2Autoimmunity, Feinstein Institute for Medical Research, Manhasset, NY

    Background/Purpose: Macrophages and dendritic cells contribute to renal damage in chronic renal diseases including lupus nephritis. However owing to their multiple phenotypic and functional variations,…
  • Abstract Number: 1196 • 2012 ACR/ARHP Annual Meeting

    Analysis of Gene Expression Patterns in Rheumatoid  Arthritis (RA) Synovial Macrophages From Patients Undergoing Disease Flare

    Karen L. Berg1, Adedayo Hanidu1, Jon Hill2, Xiaoyu Jiang1, Tom Freeman2, Jennifer Swantek1, Anna Yarlina3, George D. Kalliolias4, Lionel B. Ivashkiv5 and Gerald H. Nabozny1, 1Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, 2Scientific Knowledge Discovery, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, 3Hospital for Special Surgery, New York, NY, 4Medicine, Hospital for Special Surgery, New York, NY, 5Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY

    Background/Purpose: Synovial macrophages play a key role in RA pathogenesis.  Their numbers are greatly increased in RA synovium, their phenotype is consistent with a pro-inflammatory…
  • Abstract Number: 1078 • 2012 ACR/ARHP Annual Meeting

    Prolactin Is Increased in Responders to Anti-TNFá Treatment and the Role of the Prolactin Receptor in Rheumatoid Arthritis

    Man Wai Tang1, Danielle Marie Gerlag2, Veronica Codullo3, Elsa Vieira-Sousa4, Anne Q. Reuwer5, Marcel T. Twickler5, Robert B. M. Landewé6 and Paul Peter Tak7, 1Division of Clinical Immunology and Rheumatology & Department of Experimental Immunology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands, 2Clinical Immunology and Rheumatology, Academic Medical Center, Amsterdam, Netherlands, 3Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy, 4Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal, 5Vascular Medicine, Academic Medical Center/University of Amsterdam, Amsterddam, Netherlands, 6Academic Medical Center/University of Amsterdam & Atrium Medical Center, Amsterdam, Netherlands, 7Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) is the most common rheumatic disease which mainly affects women. In the last decade, it is known that prolactin (PRL) is…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology